Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Generation of CD4CreER(T²) transgenic mice to study development of peripheral CD4-T-cells.
Hypothesis: genetic and epigenetic risk factors interact to modulate vulnerability and resilience to FASD.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Kindler, Hedy
One or more keywords matched the following items that are connected to
Kindler, Hedy
Item Type
Name
Concept
Protein Kinase Inhibitors
Academic Article
Protein kinase C beta in malignant pleural mesothelioma.
Academic Article
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Academic Article
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report.
Academic Article
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Academic Article
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.
Academic Article
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.
Academic Article
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Search Criteria
Protein Kinase Inhibitors